CVS Health Corporation (ETR:CVS)

CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of EUR 89.33 billion. The enterprise value is 148.42 billion.

Market Cap	89.33B
Enterprise Value	148.42B

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	Oct 23, 2025

Share Statistics

Current Share Class	1.27B
Shares Outstanding	n/a
Shares Change (YoY)	-1.02%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	87.41%
Float	1.27B

Valuation Ratios

The trailing PE ratio is 23.15 and the forward PE ratio is 12.23.

PE Ratio	23.15
Forward PE	12.23
PS Ratio	0.27
PB Ratio	1.35
P/TBV Ratio	n/a
P/FCF Ratio	21.95
P/OCF Ratio	13.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.19, with an EV/FCF ratio of 36.46.

EV / Earnings	38.47
EV / Sales	0.45
EV / EBITDA	10.19
EV / EBIT	18.48
EV / FCF	36.46

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.07.

Current Ratio	0.80
Quick Ratio	0.58
Debt / Equity	1.07
Debt / EBITDA	4.88
Debt / FCF	17.31
Interest Coverage	3.05

Financial Efficiency

Return on equity (ROE) is 5.88% and return on invested capital (ROIC) is 3.66%.

Return on Equity (ROE)	5.88%
Return on Assets (ROA)	2.29%
Return on Invested Capital (ROIC)	3.66%
Return on Capital Employed (ROCE)	5.69%
Revenue Per Employee	1.26M
Profits Per Employee	14,868
Employee Count	300,000
Asset Turnover	1.50
Inventory Turnover	19.88

Taxes

In the past 12 months, CVS Health has paid 1.71 billion in taxes.

Income Tax	1.71B
Effective Tax Rate	30.89%

Stock Price Statistics

The stock price has increased by +32.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+32.12%
50-Day Moving Average	64.65
200-Day Moving Average	59.16
Relative Strength Index (RSI)	66.05
Average Volume (20 Days)	425

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Income Statement

In the last 12 months, CVS Health had revenue of EUR 327.26 billion and earned 3.86 billion in profits. Earnings per share was 3.06.

Revenue	327.26B
Gross Profit	43.54B
Operating Income	7.95B
Pretax Income	5.53B
Net Income	3.86B
EBITDA	11.90B
EBIT	7.95B
Earnings Per Share (EPS)	3.06

Balance Sheet

The company has 12.07 billion in cash and 70.44 billion in debt, giving a net cash position of -58.37 billion.

Cash & Cash Equivalents	12.07B
Total Debt	70.44B
Net Cash	-58.37B
Net Cash Per Share	n/a
Equity (Book Value)	66.03B
Book Value Per Share	52.00
Working Capital	-15.76B

Cash Flow

In the last 12 months, operating cash flow was 6.44 billion and capital expenditures -2.37 billion, giving a free cash flow of 4.07 billion.

Operating Cash Flow	6.44B
Capital Expenditures	-2.37B
Free Cash Flow	4.07B
FCF Per Share	n/a

Margins

Gross margin is 13.30%, with operating and profit margins of 2.43% and 1.18%.

Gross Margin	13.30%
Operating Margin	2.43%
Pretax Margin	1.69%
Profit Margin	1.18%
EBITDA Margin	3.64%
EBIT Margin	2.43%
FCF Margin	1.24%

Dividends & Yields

This stock pays an annual dividend of 2.36, which amounts to a dividend yield of 3.34%.

Dividend Per Share	2.36
Dividend Yield	3.34%
Dividend Growth (YoY)	-4.12%
Years of Dividend Growth	3
Payout Ratio	74.62%
Buyback Yield	1.02%
Shareholder Yield	4.36%
Earnings Yield	4.32%
FCF Yield	4.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.12 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.12
Piotroski F-Score	6